Equity Details
Price & Market Data
Price: $9.78
Daily Change: $0.00 / 0.00%
Daily Range: $9.69 - $10.21
Market Cap: $35,326,296
Daily Volume: 17,336
Performance Metrics
1 Week: 4.94%
1 Month: -20.62%
3 Months: -20.16%
6 Months: 9.15%
1 Year: 87.66%
YTD: -31.08%
About NextCure, Inc. (NXTC)
Comprehensive review of NextCure, Inc. (NXTC). Trading at 9.78, the stock has seen a daily change of $0.00 / 0.00%. Its market capitalization is 35,326,296. All performance data is available for analysis.
Company Details
Employees: 40
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.